Kangji’s indicative price range values the company at a price-to-earnings multiple of 26.2 times to 29.4 times based on its 2021 expected earnings. Photo: Shutterstock Kangji’s indicative price range values the company at a price-to-earnings multiple of 26.2 times to 29.4 times based on its 2021 expected earnings. Photo: Shutterstock
Kangji’s indicative price range values the company at a price-to-earnings multiple of 26.2 times to 29.4 times based on its 2021 expected earnings. Photo: Shutterstock

Chinese surgical instruments firm Kangji Medical to raise up to US$404 million in Hong Kong IPO, names Hillhouse Capital, BlackRock among cornerstone investors

  • Cornerstone investors take up combined US$165 million of Zhejiang province-based surgical instrument maker’s international placement tranche
  • With just four health care IPOs this year, Hong Kong faces fierce competition from Shanghai exchange

Topic |   IPO
Kangji’s indicative price range values the company at a price-to-earnings multiple of 26.2 times to 29.4 times based on its 2021 expected earnings. Photo: Shutterstock Kangji’s indicative price range values the company at a price-to-earnings multiple of 26.2 times to 29.4 times based on its 2021 expected earnings. Photo: Shutterstock
Kangji’s indicative price range values the company at a price-to-earnings multiple of 26.2 times to 29.4 times based on its 2021 expected earnings. Photo: Shutterstock
READ FULL ARTICLE